An 84-year-old gentleman was referred to the Urology Department at Bedford Hospital with a computed tomography (CT) scan revealing multiple polypoidal lesions in the urinary bladder ( Fig. 1) and bilateral pulmonary metastases. The patient initially presented to the dermatology department in May 2010 with a suspicious, raised nodular lesion on the skin of his upper back. He underwent an urgent wide local excision of the lesion in June 2010. The histopathology report revealed an ulcerated nodular malignant melanoma with a Breslow thickness of 9.6 mm and Clark level 4 with no lymphovascular or perineural invasion. The lesion was completely excised with the nearest peripheral margin at 11.5 mm and the deep resection margin at 10.5 mm. Careful surveillance was advocated and routine reviews with CT scans did not reveal any local recurrence or metastatic disease three and nine months postoperatively.
Fourteen months following diagnosis the patient developed rectal bleeding and underwent urgent colonoscopy that revealed extrinsic compression of the colon and splenic flexure. A subsequent CT scan of the chest, abdomen, and pelvis noted metastatic disease in the lungs. In the urinary bladder, a large diverticulum and multiple polypoidal lesions were identified, which initiated the urology referral.
During a flexible cystoscopy performed in September 2011, multiple pigmented lesions were identified within the bladder (Figs.  2 and 3) . Urine cytology revealed a number of scattered single cells containing pigment, positive for S100 and HMB45, and negative for Perl's stain for iron (Figs. 4 and 5) . A diagnosis of stage IV metastatic malignant melanoma with bladder involvement was made. Due to the general poor condition of the patient, the multidisciplinary team consensus was against active treatment. The patient deteriorated rapidly and died due to respiratory compromise.
DISCuSSIon
Malignant melanoma is the fifth most common cancer diagnosis in men and the seventh in women [1] . Importantly its Only 17 cases have been described in the English literature. We present a case of an 84-year-old male who was referred to the urology department with the incidental finding of bladder metastases on computed tomography (CT) one year following the diagnosis of malignant melanoma of the skin. Herein, we will discuss epidemiology, prognosis, and management options of metastatic malignant melanoma based on literature review. prevalence is increasing more rapidly than any of the other solid tumors with a five-fold increase in incidence in men over the last thirty years and three-fold increase in women [2] . Patients with stage IV disease have a poor median survival of 6-10 months with less than 5% surviving more than five years [3, 4] . Patients over the age of 65 are more likely to present with late stage disease than younger patients: 20% vs. 7% [2] . Metastases to organs other than the skin or lungs are associated with an even poorer prognosis [4] . ninety-five percent of bladder tumors are primary urothelial tumors, while other primary tumor types include adenocarcinomas, squamous cell tumors, and small cell tumors [5] . Two percent of bladder tumors are metastases from other primary tumors [6] ; the majority of these represent direct spread from adjacent organs. When considering distant metastasis the most common primary tumors are melanomas, gastric tumors, and breast tumors [7] , usually in the context of an advanced and widespread disease [8] .
The clinically evident metastatic melanoma in the bladder is rarely described and most commonly presents as painless, macroscopic hematuria (Table 1) . A subsequent diagnosis is made based on the cystoscopic findings and histopathological features combined with a clinical history of previous melanoma; though melanoma cells may have been evident on urine cytology [9] . The location of the primary lesion is also highly variable with no site predominating. Equally the lesion may present soon after the diagnosis or over 20 years later. However, despite occasionally being the first presentation of stage IV disease, they most commonly occur in the context of widespread metastatic spread and have a correspondingly poor prognosis.
Management of malignant melanoma metastases into urinary bladder consists of conservative management that involves local and systemic therapy (Table 1) . Endoscopic resection of metastatic deposits might be considered for symptoms palliation, while partial or complete cystectomy should be reserved for patients with longer life expectancy. The overall risk of complications of minimally invasive transurethral surgery is 5.1% with hematuria and bladder perforation incidence of 2.8% and 1.3%, respectively [10] . Treatments with systemic chemotherapy were reported as an adjunct to endoresection; however, this should be limited to patients with better performance status. 
